Cannabis Industry - Licensing, Investing and Proceeds
Legal Services for the UK Cannabis Industry
“They have a reputation for legal excellence which is richly deserved”
“Also of note is [their] work on the POCA issues relating to the legal sale of cannabis in the US”
The UK’s legal regime regarding the licensing of controlled drugs, arising from the Misuse of Drugs Act 1971 and involving the Misuse of Drugs Regulations 2001 and other secondary legislation, is in a state of flux. The highly publicised and reported therapeutic and medicinal benefits of certain controlled drugs, notably cannabis, have attracted particular attention in the media.
The medicinal cannabis industry is growing, both worldwide and in the UK, alongside a parallel industry in cannabidiol (CBD) ‘wellness’ products. But there are legal complexities in how such products are regarded in the UK and elsewhere, and in UK businesses’ involvement in sales of products overseas that would be unlawful if sold here (eg in Canada following the Cannabis Act), which can raise issues under the Proceeds of Crime Act 2002 (POCA).
Getting a Home Office Licence
Our lawyers have experience in advising on the legal implications of producing, importing, exporting, supplying and possessing controlled drugs, including the requirements to hold domestic, import and/or export licence(s) from the Home Office. We have helped clients through the process of obtaining licences for research into medicinal cannabis use, including liaison with the Medicines and Healthcare products Regulatory Agency (MHRA).
Whether it be the justification behind a prospective licensing application or the renewal of a licence, specialist advice is available to individuals and businesses throughout the process, including the merits of making proposals to the Home Office and the preparation of written standard operating procedures. The BCL team is highly effective at engaging with connected parties, such as those businesses involved in the production and supply chain.
Our recognised experience in controlled drugs regulation means that if there is an issue concerning a licence application, constructive and prompt legal advice is always available to an applicant to aid your ability to comply with regulatory standards and satisfy the risk-based licensing assessment process operated by the Home Office.
Proceeds of Crime Act (POCA): Issues for Investors
In addition, BCL can offer expert advice on the implications under POCA of investments and other business arrangements that may involve the proceeds of overseas sales of controlled drugs. Where the circumstances require it, we can assist with the preparation of a request to the National Crime Agency (NCA) for defences against (or ‘consent’ for) any principal money laundering offences that may be engaged.
The UK is well known for having one of the most onerous anti-money laundering (“AML”) regimes in the world, thanks to a combination of the very broadly worded criminal offences under the Proceeds of Crime Act 2002…
Drugs & Violence
The Misuse of Drugs Act 1971 is still the primary statute regulating the availability of drugs in the UK. Whilst many of the basic principles in relation to the control and criminalisation of drug use have remained unchanged for decades…
Proceeds of Crime
The Proceeds of Crime Act 2002 (“POCA”) provides a broad range of powers to the police (and other law enforcement authorities) to block, freeze, restrain, or seize assets on the basis of their connection with alleged offences or offenders…